Published in Diabet Med on July 01, 2009
GLP-1 receptor agonists: a review of head-to-head clinical studies. Ther Adv Endocrinol Metab (2015) 1.15
Exenatide once weekly treatment maintained improvements in glycemic control and weight loss over 2 years. BMC Endocr Disord (2011) 1.04
Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatment. Diabetes Care (2011) 0.97
Once-weekly exenatide versus once- or twice-daily insulin detemir: randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas. Diabetes Care (2012) 0.95
Review of head-to-head comparisons of glucagon-like peptide-1 receptor agonists. Diabetes Obes Metab (2015) 0.93
Exenatide once weekly: clinical outcomes and patient satisfaction. Patient Prefer Adherence (2010) 0.79
Exenatide extended-release; clinical trials, patient preference, and economic considerations. Patient Prefer Adherence (2013) 0.78
Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus. Diabetes Metab Syndr Obes (2010) 0.78
Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study. Health Qual Life Outcomes (2013) 0.78
Emerging role of GLP-1 receptor agonists in the treatment of obesity. Diabetes Metab Syndr Obes (2010) 0.76
Once-weekly albiglutide in the management of type 2 diabetes: patient considerations. Patient Prefer Adherence (2014) 0.76
Incorporating incretin-based therapies into clinical practice for patients with type 2 diabetes. Adv Ther (2014) 0.75
Optimizing the Care of Patients With Type 2 Diabetes Using Incretin-Based Therapy: Focus on GLP-1 Receptor Agonists. Clin Diabetes (2014) 0.75
Exenatide extended-release: a once weekly treatment for patients with type 2 diabetes. Diabetes Metab Syndr Obes (2014) 0.75
Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX) in adults with schizophrenia: study protocol for a pilot randomised controlled trial. BJPsych Open (2015) 0.75
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA (2003) 25.44
Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care (2003) 19.69
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. Diabetes Care (2005) 7.07
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study. Lancet (2008) 6.50
Development of a brief measure to assess quality of life in obesity. Obes Res (2001) 3.92
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years. Curr Med Res Opin (2008) 3.58
The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract (2007) 3.04
Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care (2002) 2.98
Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med (2005) 2.90
The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care (1994) 2.82
Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health (2006) 2.35
Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study. Curr Med Res Opin (2008) 2.24
Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care (1997) 2.21
Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes. Diabetes Care (2007) 2.14
The prevention and treatment of obesity. Application to type 2 diabetes. Diabetes Care (1997) 1.63
The mathematical relationship among different forms of responsiveness coefficients. Qual Life Res (2007) 1.53
Electronic pill-boxes in the evaluation of oral hypoglycemic agent compliance. Diabetes Metab (2005) 1.05
Randomized study of two different target levels of glycemic control within the acceptable range in type 2 diabetes. Effects on well-being at 1 year. Diabetes Care (1998) 1.01
An evaluation of an insulin transfer programme delivered in a group setting. J Clin Nurs (2007) 1.00
Evaluation of glargine group-start sessions in patients with type 2 diabetes as a strategy to deliver the service. Int J Clin Pract (2007) 0.97
Assessing weight-related quality of life in obese persons with type 2 diabetes. Diabetes Res Clin Pract (2003) 0.88
Quality of life and diabetes. Diabetes Metab Res Rev (1999) 5.37
Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med (2000) 4.40
Structure and function of the interferon-beta enhanceosome. Cold Spring Harb Symp Quant Biol (1998) 3.81
Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabet Med (2005) 3.80
Diabetes Attitudes, Wishes and Needs second study (DAWN2™): cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes. Diabet Med (2013) 2.63
Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J Biol Chem (2000) 2.62
Effect of diabetes education on self-care, metabolic control, and emotional well-being. Diabetes Care (1990) 2.60
Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia (2010) 2.50
Comprehensive DNA methylation profiling in a human cancer genome identifies novel epigenetic targets. Carcinogenesis (2006) 2.45
Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care (1997) 2.32
Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med (1991) 2.27
Features of myocardial injury in severe organophosphate poisoning. Clin Toxicol (Phila) (2014) 2.09
PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. Genes Dev (1999) 2.09
Prognostic factors and recurrence pattern in node-negative advanced gastric cancer. Eur J Surg Oncol (2012) 2.05
Successful bone-marrow transplantation for infantile malignant osteopetrosis. N Engl J Med (1980) 1.95
The impact of barriers and self-efficacy on self-care behaviors in type 2 diabetes. Diabetes Educ (2002) 1.93
Behavioral science in diabetes. Contributions and opportunities. Diabetes Care (1999) 1.85
Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine. Aliment Pharmacol Ther (2005) 1.79
Long-term preservation and storage of mycobacteria. Appl Microbiol (1972) 1.69
Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population. Diabetologia (2008) 1.67
Emergent excitations in a geometrically frustrated magnet. Nature (2002) 1.66
Psychological issues and treatments for people with diabetes. J Clin Psychol (2001) 1.65
Stenting from the vertebral artery to the posterior inferior cerebellar artery. AJNR Am J Neuroradiol (2011) 1.64
Diabetes Attitudes, Wishes and Needs second study (DAWN2™): cross-national benchmarking indicators for family members living with people with diabetes. Diabet Med (2013) 1.55
Preservation of mycobacteria: 100 percent viability of suspensions stored at -70 C. Appl Microbiol (1973) 1.54
Efficient recruitment of TFIIB and CBP-RNA polymerase II holoenzyme by an interferon-beta enhanceosome in vitro. Proc Natl Acad Sci U S A (1998) 1.54
Angiotensin-converting enzyme gene polymorphism and vascular manifestations in Korean patients with SLE. Lupus (2002) 1.53
Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes. Blood (1982) 1.52
Cross-cultural adaptation and validation of Korean Western Ontario and McMaster Universities (WOMAC) and Lequesne osteoarthritis indices for clinical research. Osteoarthritis Cartilage (2001) 1.49
Growth factor signal transduction immediately after two-thirds partial hepatectomy in the rat. Cancer Res (1999) 1.48
Coexistence of ankylosing spondylitis and mixed connective tissue disease in a single patient. Clin Exp Rheumatol (1999) 1.46
Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group. J Clin Oncol (1994) 1.45
T-category reflects the histopathologic characteristics of gallbladder cancer. Eur J Surg Oncol (2012) 1.41
Quality of marital life in Korean patients with spondyloarthropathy. Clin Rheumatol (2003) 1.40
Autologous bone marrow transplantation in non-Hodgkin's lymphoma: monoclonal antibodies plus complement for ex vivo marrow treatment. Am J Med (1988) 1.39
Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene (2011) 1.39
Subgenus classification of Acanthamoeba by riboprinting. Korean J Parasitol (1998) 1.35
Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents. Heart (2009) 1.31
Diabetes Attitudes, Wishes and Needs second study (DAWN2™): cross-national comparisons on barriers and resources for optimal care--healthcare professional perspective. Diabet Med (2013) 1.30
Nitric oxide prevents tumor necrosis factor alpha-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S-nitrosylation of caspase-8. Hepatology (2000) 1.29
A role for mitochondrial Bak in apoptotic response to anticancer drugs. J Biol Chem (2001) 1.28
Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults. Diabetologia (2011) 1.28
Persistence of depressive symptoms in diabetic adults. Diabetes Care (1999) 1.23
Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer. Cancer Gene Ther (2006) 1.23
Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice. Gene Ther (2007) 1.22
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol (2005) 1.22
Nitric oxide suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage and cytochrome c release. J Biol Chem (1998) 1.20
Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Arch Pharm Res (1998) 1.20
Spinal cord compression in malignant lymphoma. Treatment and results. Cancer (1976) 1.19
Arabidopsis eIF3e (INT-6) associates with both eIF3c and the COP9 signalosome subunit CSN7. J Biol Chem (2001) 1.19
The incidence of second neoplasms following megavoltage radiation for pediatric tumors. Cancer (1985) 1.19
Hepatic cavernous hemangioma: sonographic patterns and speed of contrast enhancement on multiphase dynamic MR imaging. AJR Am J Roentgenol (1998) 1.18
A randomized study of the prevention of acute graft-versus-host disease. N Engl J Med (1982) 1.18
Differential effect of diabetes education on self-regulation and life-style behaviors. Diabetes Care (1991) 1.17
Patient and provider perceptions of care for diabetes: results of the cross-national DAWN Study. Diabetologia (2006) 1.16
Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia. Histopathology (2007) 1.16
Formation of phalanges and small joints by tissue-engineering. J Bone Joint Surg Am (1999) 1.15
Loss of breast epithelial marker hCLCA2 promotes epithelial-to-mesenchymal transition and indicates higher risk of metastasis. Oncogene (2011) 1.14
Predictors of depressive symptoms in persons with diabetic peripheral neuropathy: a longitudinal study. Diabetologia (2009) 1.13
Mouldy houses influence symptoms of asthma among atopic individuals. Clin Exp Allergy (2002) 1.12
Phylogenetic relationships among Acanthamoeba spp. based on PCR-RFLP analyses of mitochondrial small subunit rRNA gene. Korean J Parasitol (1999) 1.09
Purification and characterization of a secretory serine proteinase of Acanthamoeba healyi isolated from GAE. J Parasitol (2000) 1.07
Structure and correlates of diabetes-specific locus of control. Diabetes Care (1994) 1.06
A placebo-controlled trial of exenatide twice-daily added to thiazolidinediones alone or in combination with metformin. Diabetes Obes Metab (2010) 1.05
Multiple heparan sulfate chains are required for optimal syndecan-1 function. J Biol Chem (1998) 1.05
Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor. Cancer Res (1996) 1.05
High levels of soluble syndecan-1 in myeloma-derived bone marrow: modulation of hepatocyte growth factor activity. Blood (2000) 1.05
Sonography of inflammatory bowel disease: findings and value in differential diagnosis. AJR Am J Roentgenol (1994) 1.03
CD28nullCD4+ T cells--characterization of an effector memory T-cell population in patients with rheumatoid arthritis. Scand J Immunol (2004) 1.03
Transcriptome analysis of channel catfish (Ictalurus punctatus): genes and expression profile from the brain. Gene (2000) 1.03
Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection. Eur J Surg Oncol (2012) 1.02
Nonlinear dynamics of domain-wall propagation in epitaxial ferroelectric thin films. Phys Rev Lett (2009) 1.02
Cross-talk between endothelial cells and tumor via delta-like ligand 4/Notch/PTEN signaling inhibits lung cancer growth. Oncogene (2011) 1.02
Cardiac tamponade as an initial manifestation of systemic lupus erythematosus--single case report. J Korean Med Sci (1997) 1.01
Thyroid dysfunction among long-term survivors of bone marrow transplantation. Am J Med (1982) 1.01
Effects of radiation on testicular function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Children Cancer Study Group. J Clin Oncol (1990) 1.01
A network meta-analysis to compare glycaemic control in patients with type 2 diabetes treated with exenatide once weekly or liraglutide once daily in comparison with insulin glargine, exenatide twice daily or placebo. Diabetes Obes Metab (2012) 1.01
Health utility values associated with diabetic retinopathy. Diabet Med (2008) 1.01
Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes. Diabetologia (2010) 0.99
Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats. Cancer Gene Ther (2008) 0.99
Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer. Br J Cancer (2013) 0.98
Galactosylated chitosan-graft-poly(ethylene glycol) as hepatocyte-targeting DNA carrier. J Control Release (2001) 0.98
Tissue-specific expression of two aldose reductase-like genes in mice: abundant expression of mouse vas deferens protein and fibroblast growth factor-regulated protein in the adrenal gland. Biochem J (1995) 0.98
Polymorphisms in the Matrilin-1 gene and risk of mandibular prognathism in Koreans. J Dent Res (2010) 0.98
Excessive Wnt/β-catenin signaling disturbs tooth-root formation. J Periodontal Res (2012) 0.97
Psychosocial problems and interventions in diabetes. A review of the literature. Diabetes Care (1992) 0.97
Galactose-carrying polymers as extracellular matrices for liver tissue engineering. Biomaterials (2005) 0.96
Clinical aspects of a rotational total skin electron irradiation. Br J Radiol (1984) 0.96
Overexpression of aldose reductase in liver cancers may contribute to drug resistance. Anticancer Drugs (2001) 0.96
Breast cancer metastatic to the tongue: report of a case. J Oral Maxillofac Surg (1986) 0.96
Impact of diagnosis of diabetes on health-related quality of life among high risk individuals: the Diabetes Prevention Program outcomes study. Qual Life Res (2013) 0.96
Pre-operative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3 cm of the anal verge. Eur J Surg Oncol (2005) 0.96
Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimer's disease. Neurobiol Aging (2009) 0.95
FOXP3 expression in blood, synovial fluid and synovial tissue during inflammatory arthritis and intra-articular corticosteroid treatment. Ann Rheum Dis (2008) 0.95
Benign and malignant esophageal strictures: treatment with a polyurethane-covered retrievable expandable metallic stent. Radiology (1997) 0.94
Depression predicts first but not recurrent diabetic foot ulcers. Diabetologia (2010) 0.94
HDAC inhibitors induce transcriptional repression of high copy number genes in breast cancer through elongation blockade. Oncogene (2013) 0.94